Shane J. Stroud’s practice focuses on all aspects of employee benefits and executive compensation, including those related to mergers and acquisitions, spin-offs, initial public offerings, private equity and leveraged buyout transactions. Shane routinely advises clients on excessive compensation, golden parachute and deferred compensation issues. He also counsels them with respect to bankruptcy, securities, corporate governance and other laws affecting employee benefits and executive compensation matters. Shane advises companies on the design and drafting of equity-based and incentive compensation plans and the implementation and design of qualified and non-qualified employee benefit plans (including health and welfare plans, 401k plans, employee stock ownership plans and supplemental executive retirement plans). Shane has extensive experience representing both executives and employers with respect to the negotiation and drafting of executive employment and severance agreements. He also advises clients on ERISA issues, including:
plan reporting and disclosure
merger and employer withdrawal liability issues.
Law Clerk, The Honorable Morey L. Sear, U.S. District Court for the Eastern District of Louisiana
Member, Rutgers Design Thinking Advisory Board
JD Sports Fashion in connection with its $558 million acquisition of Finish Line, a NASDAQ-listed retailer of athletic footwear, apparel and accessories
The Madison Square Garden
Company in its acquisition of live entertainment technology and
production company Obscura Digital
Cenveo Inc. in the sale of its office products envelope business to LSC Communications
Greenbriar Equity Group LLC in its sale of transportation management firm Transplace Holdings LLC to TPG Capital
Arsia Therapeutics in its sale to Eagle Pharmaceuticals
Madison Square Garden Company's acquisition of a majority stake in Tao Group for $181 million
Wipro’s acquisition of U.S.-based cloud services company Appirio for $500 million
Towers Watson's acquisition of Acclaris
Cigna Corporation in connection with its acquisition of Sterling Life Insurance Company from WellCare Health Plans, Inc.
Salix Pharmaceuticals, Ltd. in its $15.6 billion acquisition by Valeant Pharmaceuticals International Inc.
Acorda Therapeutics, Inc. in its acquisition of Civitas Therapeutics, Inc.
Salix Pharmaceuticals in its terminated combination with Cosmo Technologies, a subsidiary of Cosmo Pharmaceuticals
Exelon Corporation in its acquisition of Integrys Energy Services, a retail electricity and natural gas company, and ETC ProLiance Energy, a natural gas marketing company
Forbes Media LLC in its sale of a majority equity interest to a group of international investors led by Integrated Asset Management (Asia) Limited
Élan Corporation in its $8.6 billion acquisition by Perrigo Company
Brandon Point Industries Limited and Woodford Investment Management in connection with an equity investment in Viamet Pharmaceuticals Holdings, LLC
The management team of Medpace Holdings, Inc. in connection with its $930 million leveraged recapitalization sponsored by Cinven
Towers Watson’s sale of its Reinsurance Brokerage Business
Towers Watson's acquisition of Liazon Corporation
Quest Software, Inc. Chairman and CEO Vincent Smith in his going private bid for Quest Software and sale to Dell Inc.
Pfizer Inc.'s sale of its Capsugel business to KKR
DPL Inc.'s merger with AES Corp.
Pfizer Inc.'s acquisition of King Pharmaceuticals
Towers Watson's acquisition of Extend Health
Angiodynamics' acquisition of Navilyst Medical
Secured Lenders in the Chapter 11 bankruptcy proceedings of radio station operator Inner City Media Corporation
Vertis in connection with its Chapter 11 bankruptcy proceedings and sale of substantially all of its assets to Quad/Graphics
Icahn Capital in its bid for the assets of Blockbuster, Inc.